102 related articles for article (PubMed ID: 9190931)
1. A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.
Wang W; Gulden PH; Pierce RA; Shabanowitz J; Man ST; Hunt DF; Engelhard VH
J Immunol; 1997 Jun; 158(12):5797-804. PubMed ID: 9190931
[TBL] [Abstract][Full Text] [Related]
2. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL.
Poindexter NJ; Naziruddin B; McCourt DW; Mohanakumar T
J Immunol; 1995 Apr; 154(8):3880-7. PubMed ID: 7535816
[TBL] [Abstract][Full Text] [Related]
4. Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone.
Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
J Immunol; 1996 Jul; 157(2):670-8. PubMed ID: 8752916
[TBL] [Abstract][Full Text] [Related]
5. Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide/MHC complexes.
Malarkannan S; Gonzalez F; Nguyen V; Adair G; Shastri N
J Immunol; 1996 Nov; 157(10):4464-73. PubMed ID: 8906823
[TBL] [Abstract][Full Text] [Related]
6. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
7. Allo-cross-reactivity of a human neuraminidase-specific T cell clone dependent on presentation of an endogenous B cell-specific antigen.
Kuijpers KC; Treep-Van Leeuwen P; Miedema F; Lucas CJ
Eur J Immunol; 1991 Jun; 21(6):1453-60. PubMed ID: 1710566
[TBL] [Abstract][Full Text] [Related]
8. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes.
Clayberger C; Parham P; Rothbard J; Ludwig DS; Schoolnik GK; Krensky AM
Nature; 1987 Dec 24-31; 330(6150):763-5. PubMed ID: 3501071
[TBL] [Abstract][Full Text] [Related]
9. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
Smith KD; Lutz CT
J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
[TBL] [Abstract][Full Text] [Related]
10. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
Heath WR; Hurd ME; Carbone FR; Sherman LA
Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
[TBL] [Abstract][Full Text] [Related]
11. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity.
Müllbacher A; Hill AB; Blanden RV; Cowden WB; King NJ; Hla RT
J Immunol; 1991 Sep; 147(6):1765-72. PubMed ID: 1890303
[TBL] [Abstract][Full Text] [Related]
12. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
13. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
Hornell TM; Solheim JC; Myers NB; Gillanders WE; Balendiran GK; Hansen TH; Connolly JM
J Immunol; 1999 Sep; 163(6):3217-25. PubMed ID: 10477590
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides.
Schendel DJ; Reinhardt C; Nelson PJ; Maget B; Pullen L; Bornkamm GW; Steinle A
J Immunol; 1992 Oct; 149(7):2406-14. PubMed ID: 1326579
[TBL] [Abstract][Full Text] [Related]
15. Peptide HER2(776-788) represents a naturally processed broad MHC class II-restricted T cell epitope.
Sotiriadou R; Perez SA; Gritzapis AD; Sotiropoulou PA; Echner H; Heinzel S; Mamalaki A; Pawelec G; Voelter W; Baxevanis CN; Papamichail M
Br J Cancer; 2001 Nov; 85(10):1527-34. PubMed ID: 11720440
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as a source of high avidity peptide-specific human CTL.
Münz C; Obst R; Osen W; Stevanović S; Rammensee HG
J Immunol; 1999 Jan; 162(1):25-34. PubMed ID: 9886366
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
Jones MA; Hislop AD; Snaith JS
Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
[TBL] [Abstract][Full Text] [Related]
18. Recognition of an antigenic peptide derived from tyrosinase-related protein-2 by CTL in the context of HLA-A31 and -A33.
Wang RF; Johnston SL; Southwood S; Sette A; Rosenberg SA
J Immunol; 1998 Jan; 160(2):890-7. PubMed ID: 9551926
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
[TBL] [Abstract][Full Text] [Related]
20. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
